| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/24/2000 | CA2339143A1 Phosphorylated polymers and conjugates thereof |
| 02/24/2000 | CA2338283A1 Multivalent avb3 and metastasis-associated receptor ligands |
| 02/23/2000 | EP0980376A1 Method for producing carbohydrate partial esters |
| 02/23/2000 | EP0980369A1 Sulfonamides for treatment of endothelin-mediated disorders |
| 02/23/2000 | EP0980269A1 Biodegradable compositions comprising poly(cycloaliphatic phosphoester) compounds, articles, and methods for using the same |
| 02/23/2000 | EP0980262A1 Solid pharmaceutical formulations containing a physical mixture of sulfoalkyl ether cyclodextrin and a therapeutic agent |
| 02/23/2000 | EP0980245A1 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure erectile dysfunction |
| 02/23/2000 | EP0980240A1 Sustained-release compositions and method for preparing same |
| 02/23/2000 | EP0806933A4 Formulations and methods for reducing skin irritation |
| 02/23/2000 | CN1245436A Pharmaceutical formulations for sustained drug delivery |
| 02/23/2000 | CN1245435A Pharmaceutical compositions containing gellants in form of alkyl amides of di- and tri-carboxylic acids |
| 02/23/2000 | CN1245434A Stable liquid interferon formulations |
| 02/23/2000 | CN1245431A Medical composition and use thereof for manufacture of topical barrir formulation, UV-radiation absorbing formulation, or antiviral, antifungal, or antiinflammatory formulation |
| 02/23/2000 | CN1245425A Poly(diallylamine)-based bile acid sequestrants |
| 02/23/2000 | CN1245423A Formulation and method for treating neoplasms by inhalation |
| 02/23/2000 | CN1245161A Process for preparing chromium L-threonate, its preparing process and application |
| 02/23/2000 | CN1049576C Hard porous foam embolus and its manufacturing technology |
| 02/22/2000 | US6028222 Stable liquid paracetamol compositions, and method for preparing same |
| 02/22/2000 | US6028174 Method of diagnosing and treating gliomas |
| 02/22/2000 | US6028170 Analogs of hirudin |
| 02/22/2000 | US6028164 Bioresorbable compositions for implantable prostheses |
| 02/22/2000 | US6028108 Propofol composition comprising pentetate |
| 02/22/2000 | US6028105 Topical drug delivery composition and method |
| 02/22/2000 | US6028065 As anticarcinogenic agent |
| 02/22/2000 | US6028057 Inducing pseudopregnancy in fertile female pigs comprising administering to the pigs an effective amount of a compound that induces pseudopregnancy in a biodegradable controlled release formulation |
| 02/22/2000 | US6028054 Method for increasing bioavailability of oral pharmaceutical compositions |
| 02/22/2000 | US6027732 Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances |
| 02/22/2000 | US6027730 Herpes simplex vaccine comprising HSV glycoprotein GD and 3 deacylated monophosphoryl lipid A |
| 02/22/2000 | US6027726 Liposome consisting essentially of a steric barrier molecule and a sulfhydryl-reactive lipid and attached to an oxidized antibody by a crosslinking agent having an acid hydrazide functionality on one end and a sulfhydryl on the other; drugs |
| 02/22/2000 | US6027715 Composition and means for treating dry mouth |
| 02/22/2000 | US6026815 Radiopaque liquid as radiation blocking agent |
| 02/22/2000 | CA2258095C Tetrahydrolipstatin containing compositions |
| 02/22/2000 | CA2176713C Amphiphilic imidazolinium derivatives |
| 02/22/2000 | CA2023563C Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method |
| 02/17/2000 | WO2000008467A2 Treatment of bacterial infections |
| 02/17/2000 | WO2000008092A1 Controlled release polyacrylic acid granules and a process for preparing the same |
| 02/17/2000 | WO2000008061A1 Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions |
| 02/17/2000 | WO2000008031A1 Novel phospholipids with unsaturated alkyl and acyl chains |
| 02/17/2000 | WO2000008004A1 Particle-forming compositions containing fused pyrrolocarbazoles |
| 02/17/2000 | WO2000007982A1 Saturated and unsaturated abietane derivatives, derived conjugates and uses in a diagnostic composition, a reagent and a device |
| 02/17/2000 | WO2000007979A2 Compounds and compositions for delivering active agents |
| 02/17/2000 | WO2000007630A1 Nucleic acid delivery |
| 02/17/2000 | WO2000007629A2 Peg-urate oxidase conjugates and use thereof |
| 02/17/2000 | WO2000007628A1 STABILIZED PREPARATIONS OF β-LACTAM ANTIBIOTIC |
| 02/17/2000 | WO2000007627A2 Topical delivery systems for active agents |
| 02/17/2000 | WO2000007625A1 Targeting and prolonging association of drugs to the luminal surface of the pulmonary vascular endothelial cells |
| 02/17/2000 | WO2000007620A1 Protease inhibitors for use in the treatment of psoriasis |
| 02/17/2000 | WO2000007605A1 Use of camptothecin derivatives, with reduced gastrointestinal toxicity |
| 02/17/2000 | WO2000007603A2 End modified thermal responsive hydrogels |
| 02/17/2000 | WO2000007601A1 Ophtalmic solution with tetracycline for topical treatment of dry eye disease |
| 02/17/2000 | WO2000007597A1 Transmucosal therapeutic system for administering sildenafil |
| 02/17/2000 | WO2000007588A1 Pharmaceutical composition for injection based on paracetamol |
| 02/17/2000 | WO2000007573A1 Composition with prolonged release of active principle capable of forming a micro-emulsion |
| 02/17/2000 | WO2000007572A2 Two-piece capsule for receiving pharmaceutical preparations for powder inhalers |
| 02/17/2000 | WO2000007570A1 Pharmaceutical compositions comprising ibuprofen and domperidone |
| 02/17/2000 | WO2000007569A1 Compressed compositions comprising clarified xanthan gum |
| 02/17/2000 | WO2000007568A1 Method for making coated gabapentine or pregabaline particles |
| 02/17/2000 | WO2000007567A1 Medicinal aerosol formulations |
| 02/17/2000 | WO2000007564A1 Foaming oil preparation and its use |
| 02/17/2000 | WO2000007549A1 Finely dispersed emulsifier-free systems of the oil-in-water and water-in-oil type, containing boron nitride |
| 02/17/2000 | WO2000007548A1 Finely dispersed emulsifier-free systems of the oil-in-water and water-in-oil type |
| 02/17/2000 | WO2000007547A1 Finely dispersed emulsifier-free systems of the oil-in-water and water-in-oil type |
| 02/17/2000 | WO2000007543A2 Conjugates targeted to the interleukin-2 receptors |
| 02/17/2000 | WO1999065448A3 Cosmetic or dermopharmaceutical composition in the form of beads and methods for preparing same |
| 02/17/2000 | WO1999055332A8 Medicinal compositions |
| 02/17/2000 | DE19913697A1 Joint pain alleviating composition containing purified silica used for treating rheumatic diseases such as lumbago or arthritis |
| 02/17/2000 | DE19836960A1 Production of high-purity alginate useful for making capsules of encapsulating implants comprises extraction, sedimentation, filtration and precipitation |
| 02/17/2000 | DE19836646A1 Verwendung von N-Vinylpyrrolidon- und Vinylacetat-haltigen Copolymeren als Matrix zur Herstellung von festen, oralen pharmazeutischen und kosmetischen Zubereitungen Use of N-vinylpyrrolidone and vinyl acetate-containing copolymers as matrix for producing solid oral pharmaceutical and cosmetic preparations |
| 02/17/2000 | DE19830240C1 Wachsester mit vaselineähnlicher Konsistenz, Verfahren und Verwendung Wax esters with vaselineähnlicher consistency, process and |
| 02/17/2000 | CA2728907A1 Peg-urate oxidase conjugates and use thereof |
| 02/17/2000 | CA2340020A1 Use of camptothecin derivatives, with reduced gastrointestinal toxicity |
| 02/17/2000 | CA2339485A1 Protease inhibitors for use in the treatment of psoriasis |
| 02/17/2000 | CA2339231A1 Topical delivery systems for active agents |
| 02/17/2000 | CA2339198A1 Treatment of bacterial infections |
| 02/17/2000 | CA2339102A1 Saturated and unsaturated abietane derivatives, derived conjugates and uses in a diagnostic composition, a reagent and a device |
| 02/17/2000 | CA2339085A1 Conjugates targeted to the interleukin-2 receptors |
| 02/17/2000 | CA2338173A1 Method for making coated gabapentine or pregabaline particles |
| 02/17/2000 | CA2280449A1 Stabilized protein compositions |
| 02/16/2000 | EP0979655A1 Means for treatment of infections caused by RNA-Virusses such as HIV |
| 02/16/2000 | EP0979654A1 Activated vitamin d 3? emulsion-type lotions |
| 02/16/2000 | EP0979649A2 Use of copolymers comprising N-vinylpyrrolidone and vinylacetate for the production of solid oral pharmaceutic and cosmetic compositions |
| 02/16/2000 | EP0979648A2 Microspheres of esters of hyaluronic acid for controlled release of an active |
| 02/16/2000 | EP0979614A2 Method of producing iron-whey-proteolysate complex |
| 02/16/2000 | EP0979309A1 Oligonucleotides for enhanced bioavailability |
| 02/16/2000 | EP0979292A2 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety |
| 02/16/2000 | EP0979243A2 Activation of peptides |
| 02/16/2000 | EP0979225A1 Compounds and compositions for delivering active agents |
| 02/16/2000 | EP0979122A1 Targeted therapy to a biomedical device |
| 02/16/2000 | EP0979104A1 Sonodynamic therapy using an ultrasound sensitizer compound |
| 02/16/2000 | EP0979102A1 Polyalkylene oxide-modified single chain polypeptides |
| 02/16/2000 | EP0979100A1 ANTI-$i(HELICOBACTER) VACCINE COMPOSITION COMPRISING A TH1 ADJUVANT |
| 02/16/2000 | EP0979072A1 Transdermal device for the delivery of testosterone |
| 02/16/2000 | EP0979071A1 Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstream |
| 02/16/2000 | EP0979032A2 Method of making controlled release devices |
| 02/16/2000 | EP0694310B1 Reversible, thermally gelling water-base medicinal composition |
| 02/16/2000 | EP0642335B1 Controlled release preparation containing a salt of morphine |
| 02/16/2000 | CN1244869A Crystal form O of clarithromycin |
| 02/16/2000 | CN1244806A Compositions for transdermal administration of streoid drugs |
| 02/16/2000 | CN1244805A Stable lyophilized pharmaceutical substance from monoclonal or polyclonal antibodies |
| 02/16/2000 | CN1244797A Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid |